Tazarotene Gel

About Solaris Pharma Corporation

Solaris Pharma Corporation, founded in 2018, is a privately held, revenue-generating company specializing in complex generic and specialty pharmaceuticals. Its strategy centers on developing difficult-to-manufacture products in dosage forms like topicals, sterile injectables, and tablets, which face high development hurdles but offer attractive market opportunities with limited competition. Led by CEO Shalin Jani, the company has a validated development process, multiple product approvals, and a commercial track record, positioning it as a dependable supplier in a niche segment of the pharmaceutical industry.

Therapeutic Areas